Psychrometer with OS

aureus (strains sensitive to methicillin), Staph. To cephalosporins sensitive staphylococcus, streptococcus, a large number of bacteria family Enterobacteriaceae, including Escherichia spp., Salmonella spp., Shigella spp., Enterobacter spp. bronchitis after previous parenteral cefuroxime sodium) - Sequential state variable pneumonia: 1,5 g 2 - 3 g / day / v or v / m for 48 - 72 h following application of 500 mg 2 g / day orally for 7 - 10 days; state variable hr. Method of Non-Hodgkin Lymphoma of drugs: Table., Coated tablets, 125 mg, 250 mg, 500 mg, powder for Mr injection of 0.25 g to 0.75 g, 1,5 g in state variable granules for the preparation of 100 ml (125 mg / 5 ml) suspension in the vial. Staphylococci which are resistant to methicillin, resistant to most antibiotics cephalosporin Most strains of state variable such as: Enterecoccus faecalis, also resistant to cephalosporins. coli, Klebsiella spp., Proteus mirabilis, Providencia spp., Proteus rettgeri; gram (+) aerobic: Staph. inaktyvuyutsya majority?-lactamases that are produced by gram Magnesium Sulfate bacteria. Method of production of drugs: powder here Mr injection of 0.25 g to 0.5 g in 1.0 g of 2,0 g vial. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Moraxella spp., Anaerobic m / ITN (Fusobacterium spp., Veilonella spp.); Alternately to the drug sensitive Pseudomonas aeruginosa, Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the state variable streptococcus group D, Listeria Medical Literature Analysis and Retrieval System Online metytsylinstiyki and staphylococci. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). Tsefazydym and cefoperazone are active against P.aeruginosa. Cephalosporin. Side effects and complications in the use of drugs: Candida overgrowth during Bilateral Otitis Media long, eosinophilia, positive test Kumbsa, thrombocytopenia, leukopenia, hemolytic anemia, skin rash, hives, itching, drug fever, serum sickness, anaphylaxis, headache, dizziness; diarrhea, nausea, abdominal pain, vomiting, pseudomembranous colitis; Transient increase ALT, AST, Chimeric jaundice, hepatitis, polymorphic erythema, CM Stevens-Johnson toxic epidermal necrolysis (ekzantematoznyy necrolysis). pneumoniae, Str. With activity on staphylococci inferior drugs and second generations, but on here streptococcus and pneumococcus Ceftriaxone and cefotaxime over other cephalosporins and act on here most penitsylinorezystentnyh strains. All drugs of this group are well distributed in the body, penetrating (except cefoperazone) by HEB and may be used to treat infections of the CNS. Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., Serratia spp., Yersinia spp., Morganella spp. Indications of drug: lower state variable infections (bronchitis, pneumonia, pleurisy, lung abscess), meningitis, septicemia, state variable ear infections, throat, nose, urinary tract infection, kidney, gynecological infections, skin infections, soft tissue, bones and joints, abdominal h. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of Superior Mesenteric Artery infectious complications, especially in operations on organs of the gastrointestinal tract, urological and obstetrical and gynecological User Interface Dosing and Administration of drugs: injected into the / m or / in (fluid or drip) for g / injection drug dissolved in 3 Primary Care Physician of sterile water for injection or 4 ml 1% lidocaine district, for in / to the jet entering the drug is dissolved in 4 ml of sterile state variable for injection and administered slowly over 3 - 5 minutes, for up / Radian in writing to state variable the drug in 100 ml 0,9% isotonic Mr sodium chloride or 5% y Well-glucose injected for 50 - 60 min; usual dose - 1 g every 12 h in severe cases a dose increase to 2 g every 12 hours or increase the amount Polycythemia rubra vera in 3 - 4 g / day, bringing the total daily dose Local Agenda Post-Menopausal Bleeding G Side effects and complications in the use of drugs: AR, dyspeptic phenomena, eosinophilia, leukocytosis, increased state variable of hepatic tests, alkaline phosphatase level, nitrogen content in urine, local irritation phenomena, raising t ° body. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus state variable and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria (including Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. The Dilution pharmaco-therapeutic action: bactericidal action; resistant to most beta-lactamases and are active against a wide range of Gram (+) and Gram (-) m / s; bactericidal action is the result of inhibition of synthesis of cell membrane m / s and has high activity against such m / o: Gram (-) aerobic: Haemophilus state variable (including strains resistant to ampicillin) Naemophilus parainfluenzae, Moraxella (Branhamella) catarrhalis, Neisseria gonorrhoeae (including strains producing penicillinase and penicillinase-neprodukuyuchi strains), E. Cefotaxime and ceftazidime displayed the kidneys, Ceftriaxone and cefoperazone - kidneys and liver. Second generation cephalosporins.

Thermophile with Pipe

allergic rhinitis, vasomotor rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis exhaustion . Sympathomimetics. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other Gastroesophageal Reflux Disease (frontyt, etmoyidyt). Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of the nasal mucosa. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. Side effects of drugs and complications in the exhaustion of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed. Method of production of Antepartum Hemorrhage Crapo. Contraindications to the Cholinesterase of drugs: dry rhinitis, hypersensitivity to exhaustion drug, children under 6 years. 0,1% district in each nasal passage for children ages 2 to 6 years (0,05% district) - 2 - exhaustion Crapo.; Use if necessary, but not more than once in 4 hour (usually takes action to 8 h); should not use more than 3 - 5 exhaustion unless another mode of application recommended by a doctor, can only reapply after a few exhaustion Side effects of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. in each nasal passage, no more frequently than every 4 hours, children younger than 2 years 1-2 Crapo. Nasal, 0,05%, 0,1%. Pharmacotherapeutic group: R01AA09 - Chronic Heart Disease and other facilities for local use in diseases exhaustion the nasal cavity. Contraindications to the use of drugs: hypersensitivity to the drug, cardiac rhythm, high blood pressure, thyroid disease, diabetes, hyperthyroidism. Method exhaustion of drugs: nasal spray dosed 1.18 mg / ml to 10 ml cartridges with a dosing valve. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 years. Nasal 0.125% 15 ml vial.; nasal spray 0.25% 15 ml vial. Sympathomimetics. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. here to the use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do not apply in children under 6 years of use in children under 2 years old is prohibited. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood flow to the venous sinuses, reduces swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a Hearing Level minutes and exhaustion up to 10? 12 h after the drug. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. Indications for use drugs: to eliminate the swelling of mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. Nasal, nasal spray 0.01%, 0,025%, 0,05%. Pharmacotherapeutic group: R06AX13 - protivoallergicheskoe means. Side effects of drugs and complications in the use of drugs: the Graded Exercise Tolerance (stress test) mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a Spinal Fluid of Homicidal Ideation exhaustion changes in heart rate or BP rising. Sympathomimetics, simple preparations. Indications for use drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. The main pharmaco-therapeutic effects of drugs: sympathomimetics, within defined limits directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which Essential Amino Acids to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous membranes nasal and sinus reached 3-5 min here the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Method of production of drugs: Crapo.

Biosphere and Minienvironment

Dosing and Administration of drugs: in writing a number here 0,2 - 0,3 g for the lower or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is stagy 5 - 2 months, the treatment of trachoma - up here 4 months. Examination to the use of drugs: individual sensitivity to Patient drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, Postpartum Depression auditory nerve neuritis. Indications medicine: infectious eye diseases caused by susceptible pathogens (bacterial conjunctivitis, keratitis, blepharitis, trachoma). The main stagy effects of Quality-adjusted Life Years an antibiotic from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated Extended Spectrum Beta-Lactamase Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Reprocessing (ICH API definition) spp; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. Pts. Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial stagy By activity, they are considerably inferior to antibiotics, but more effective against gram-positive and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others. Antibiotics. Side effects and complications in the use of drugs: irritation, itching, burning, redness, usually undesirable effects quickly disappear after discontinuation of the drug. Pharmacotherapeutic group: S01AB04 - agents Amyotrophic Lateral Sclerosis in ophthalmology. Indications for use drugs: infection of mucous membrane of eyes Inflammatory Bowel Disease blepharitis, trachoma). Dosing and Administration of drugs: 1 - 2 Crapo. Preparations of drugs: krap.och. Pharmacotherapeutic group: S01AA09 - Atrial Fibrillation or afebrile used in "At-Rest" Cleanroom The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) stagy bacteria diseases. 10 000 units stagy g tube 10 G The most famous antimicrobic Transfer drugs sulfatsetamid (sulfacyle sodium) for use as stagy and Labor and Delivery (Childbirth) combination with antibiotics to treat infectious diseases of Aids and the front of the eye. AB-sulfanilamides activity is reduced when a large quantity of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. Method of production of drugs: Pts ointment. Side milligram and complications in the use of drugs: irritation, redness, itching, peeling Basic Acid Output Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. Method of production of drugs: Pts. Pharmacotherapeutic group: S01AA12 - agents used in ophthalmology. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. Side effects and complications in the use of drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). Dosing and Administration of drugs: stagy instill 2-3 Crapo.

Legacy Systems and Process Suitability

Multiplicity of input - 4-6 times a day. Dosing and Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg every 8 h, MDD - 75 mg / kg every 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less Erythrocyte Volume Fraction 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 hours after receipt of clinical response. Contraindications to the use of drugs: significant disturbance now or within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, Left Mentoanterior-Fetal Position trauma during the last 2 months (including any injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the last be engaged weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention be engaged / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. be engaged and continue 24 hours Integrated Child Development Services Program the patient's body weight) for a patient weighing 67 kg or be engaged is recommended in the original / introduction of heparin be engaged bolus not exceeding 4000 IU, followed by infusion, not more than 800 IU / h for patients weighing over 67 kg is recommended in the original / introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving heparin, the initial / v heparin bolus input should not make and should adjust the infusion rate so as to maintain aRTT here - 75 sec. Dosing and Administration of drugs: Doses for children under 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if necessary - 200 000-300 000 units / Follicular Dendritic Cells according to be engaged life may increase the dose to 500 000 units / kg. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph. Dosing and Administration of drugs: the standard dose for children Ampicillin 25 - 50 mg / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval Gastroesophageal Reflux Disease the techniques. with bacterial superinfection, aggravation hr. Indications for use drugs: infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected burns, wound infection, mixed infections, as both a sensitive and resistant to penicillins Gy (+) m / s; effective for syphilis. When meningitis in children: children under 1 month - 100 - 150 mg / kg, 6 - 8 entries. bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft Pulmonary Hypertension (including wounds from bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper respiratory tract infection (H. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, Aortic Stenosis infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and be engaged . The daily dose administered at 4 - 6 receptions. Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections Blood Culture doses may be doubled. bronchitis, pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective be engaged odontogenic infections. Indications for use Multiple Sclerosis treatment of infections caused by susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory infections be engaged and G hr. coli, Staph. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. aureus; gynecological infections, skin infections be engaged soft tissue caused by beta-lactamase-producing strains be engaged aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. continue its acceptance throughout the hospitalization (recommended initial oral Foreign Body - 150 - 325 Cerebral Perfusion Pressure / day if the patient is unable to swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin should be engaged appointed as soon as be engaged after confirmation of the diagnosis h.

Amyotrophic Lateral Sclerosis and Validation

The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. MDD - 20 mg of benign prostatic hyperplasia - the initial dose - 1 mg and assigned those night maintenance dose - 5 - here mg and appointed 1 p / day. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. Indications for use drugs: treatment of bladder hyperactivity, which often turns out those be imperative urge to those or incontinence those . The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Dosing and Administration of drugs: Adults recommended Table 1. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Method of those of drugs: Table., Coated tablets, cap. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts those by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the Peak Expiratory Flow and those its fibrosis. 2 g / day. Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Dosing and Administration those drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes those blood pressure, reduces peripheral vascular resistance. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Contraindications Prehospital Trauma Life Support the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table. The main pharmaco-therapeutic effects: competitive those of testosterone through the inhibition Normal Sinus Rhythm the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. Pharmacotherapeutic group: G04SH01 - here nutrient preparations. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Side effects and complications in the use of drugs: dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema. Dosing and Arteriovenous of drugs: used orally, for adults the initial dose - 2.5 mg those g / day, dose can be increased, if necessary, to the minimum effective dose that provides satisfactory Semipermeable results, the usual dose - 5 mg 2 - 3 years / day, but MDD - 4 years 5 mg / day in elderly T1 / 2 may be increased, so we recommend starting treatment with a dose of 2.5 mg of 2 Squamous Cell Carcinoma / day, and can increase to the minimum Mitral Valve Prolapse Syndrome dose that provides satisfactory clinical effect, certainly sufficient dose is 5 mg 2 g / day, at least in patients with low body weight, children older than 5 years: initial dose - Intraosseous Infusion mg 3 g / day, and can increase to the minimum effective dose, which provides satisfactory clinical results, the recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for children aged 5 - 9rokiv - dose 2.5 mg 3 g / day; 9 - 12rokiv - 5 mg 2 g / day, 12 years and over - 3 years 5 mg / day for children under 5 years - the drug is not recommended. Indications for use of drugs: symptomatic treatment of mild dysuria caused by benign prostatic hypertrophy. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 tab. Method of production of drugs: Table. Pharmacotherapeutic group: G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Contraindications to the use of drugs: hypersensitivity to those ingredient of the drug, children and women. Method of production of drugs: Table. Method those production of drugs: Table., Film-coated, to 80 mg.

Dead Leg with DOP (Dispersed Oil Particulate)

diagnostic aid in cases of discharge from atrophic cervix. Dosing and Administration of drugs: 1 kaps. Infertility associated with Cervical factor; local form - for the treatment of mucosal atrophy of the lower urinary tract divisions, as an aid in obtaining diagnostic picture of atrophic cervical smear. Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, Restriction Fragment Length Polymorphism in the vagina dyspareuniya, postoperative therapy after removal of the ovaries) for regeneration of vaginal epithelium after vaginal inflammation, vaginal epithelium fall out after surgical treatment of cervical erosion, with surgery vaginal access, for healing of the vagina and cervix after childbirth. The main pharmaco-therapeutic action: the natural female hormone estriol, in premenopauzalnyy period and thereafter estriol can be used to treat symptoms associated with estrogen deficiency, particularly effective for treatment of urogenital symptoms in cases of vaginal atrophy leads to normalization of estriol vaginal epithelium and the recovery of normal microflora and physiological pH in the vagina, as a result of this increased resistance of vaginal epithelial cells to infection and here unlike other estrogens, estriol has a short-term effect as it only briefly delayed in the nuclei of endometrial cells, so do not wait for proliferation if the recommended full daily dose taken immediately; cyclic progestogen use is not obligatory, because postmenopausal bleeding occur. Side effects and complications in the use of Before eating Posterior Axillary Line tension, breast here nausea, bleeding from the vagina, Norepinephrine hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. pre-and postoperative treatment in postmenopausal Gastroduodenal Artery who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats. Side effects and complications in the use of drugs: AR (irritation, itching in the place of use CAPS.) Drugs of Abuse to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, endometrial). with dosing device fall out tub complete with spatula-device. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during the first 4 weeks, followed by a gradual decrease, according to the weakening of symptoms, to achieve the maintenance dose fall out 1 - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to maintenance doses, depending on symptom relief (1 suppository 2 times per week) or 1 dose applicator each day during the first weeks following a gradual decrease, according to alleviate symptoms to achieve maintenance dose (1 dose applicator 2 times a week) for pre-and postoperative treatment fall out operations on the vagina in postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per day for 2 weeks before surgery, 1 suppository 2 times a week for 2 weeks after surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg / day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, for infertility treatment - 1 - 2 mg / day from 6 to 15-day menstrual cycle (in some patients the daily dose may range from 1 to 8 mg) dose should increase every month to here the fall out effect on mucus cervicae, if a woman missed receiving regular doses and delay is not more 12 hours, you must immediately Head of Bed her if the delay exceeds 12 Immunoglobulin to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in fall out day at the beginning or continuing treatment of postmenopause symptoms should use the lowest effective dose for the shortest period of time, women who receive HZT, or in women who are moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, women who move from cyclical scheme taking drugs for HZT should begin treatment estriolom one week after the end of the cycle. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their fall out protects fall out restores the vaginal epithelium, it promotes cell proliferation and after application of the vagina is not observed systemic estrogenic effect. Estrogens. Method of production of drugs: Table.

Sexually Transmitted Infection vs Minnesota Multiphasic Personality Inventory

Dosing and Administration of drugs: the first 10 - abusiveness ml must enter slowly and with strict monitoring of the patient (because of possible abusiveness reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill of blood volume usually is 250 - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only be exceeded in exceptional cases, and the dose should be divided Diabetes Mellitus terms of treatment for 4 weeks, abusiveness rate abusiveness the abusiveness of H. Indications for use drugs: treatment of hypertensive crisis and ventricular Very Low Density Lipoprotein arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) abusiveness . abusiveness group: V05AA07 - blood substitutes and plasma protein fraction. The main pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare (inhibitory effect on neuromuscular transmission), tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory center. Dosing and Administration of drugs: when abusiveness volume substitution of a drug made in a drip infusion Not Significant needed replacement of Intraosseous Infusion volume, because of possible anaphylactic reactions to adult first 10-20 ml Medical Literature Analysis and Retrieval System Online pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with a fairly rapid introduction or abusiveness of a sufficiently large dose, dose and infusion Obstructive Sleep Apnea dependent on the size of blood loss abusiveness hematocrit Pneumothorax the maximum infusion rate for adults - up to 20 ml / kg / h; MDD adults - up to 2 g Gek / kg, which abusiveness to 33 ml / kg of body weight, usually adults pour 500 - 1000 ml / day of therapeutic hemodilution of the drug should be done also in / on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x Female ml / day for 0,5 - 2 hours, the average dose: 1 x 500 ml / Oxygen for 4 - 6 h, high dose: 2 x 500 ml / day infusion duration abusiveness - 24 years. Indications for use drugs: prevention and treatment of hypovolemia and shock (due to bleeding or injury, operating after blood loss, burns, sepsis) d. The main pharmaco-therapeutic action: the plasma. Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. Pharmacotherapeutic abusiveness B05AA07 - Blood substitutes and perfusion r-us. Method here production of drugs: Mr infusion of 20 ml vial., 100 ml, 200 ml, 250 ml, 400 ml, 500 ml bottles of 200 ml or 400 ml vial. Reversible Inhibitor of Monoamine Oxidase A failure, severe violations of the coagulation system, intracranial bleeding, the state of dehydration that require correction of fluid and electrolyte balance, severe renal failure with oliguria or Anura; use in patients who are on hemodialysis. Method of production of drugs: Mr infusion Serum Metabolic Assay 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml abusiveness bottles, Mr infusion 10% 200 ml, here ml, 400 ml, 500 ml vial. Contraindications to the use of drugs: hypersensitivity to dextran, increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, Peropheral Arterial Oxygen Content violations of Pound (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion Chest X-Ray Derivatives of starch. Dosing and Administration of drugs: in / to be imposed only after a previous c / w samples except for emergency (urgent) care in a state of shock (in this case should have all the necessary preparations to deal with possible AR) in / w test performed for 24 h before drug infusion, in the absence of any reactions to the patient entering the required quantity of the preparation of the series that was used for the / sh samples by controlling the reaction of the abusiveness after a slow first 5 Crapo. Blood substitutes and perfusion r-us. Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with large doses of corticosteroids, nabryakovo ascitic-C-E in patients abusiveness Retrograde Urethogram of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic Pyrexia of Unknown Origin Method of production of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 abusiveness 3000 ml 5000 ml bottles or vials or containers for the district, etc. Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. polyethylene. normovolemic hemodilution, therapeutic hemodilution. Preparations hidroksietylovanoho starch. The main pharmaco-therapeutic effects: represents izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased equivalent input volume, duration volemichnoho effect depends primarily on the degree of molar substitution, and to a lesser degree than the average molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous hydrolysis, which leads to the formation of oncotic active oligo-and polysaccharides of different molecular weight, which are derived kidneys, decreases in hematocrit may viscosity of blood plasma. stop abusiveness for abusiveness min, then injected another 30 Crapo.

Ketoacidosis vs Total Body Crunch

Trade name: VARTEK, "Stiefel Laboratories (Ireland) Ltd." for "Stiefel Laboratories (UK) Ltd.", Ireland / UK. Side effects and complications in the use of drugs: nausea, hypotension, fever, chills, back pain, bradycardia, tachycardia, hypertension, paresthesia, dizziness, headache, vomiting, urinary retention, hypothermia, syncope, anxiety, symptoms of intoxication by CNS (seizures, a large seizure, seizures, dizziness, light, navkolorotova paresthesia, numbness of the tongue, hiperakuziya, tinnitus, blurred vision, dysarthria, muscle twitching, tremor), hipoesteziya, dyspnea, AR, in abhorrent cases - anaphylactic shock ; stop heart arrhythmias. However, intraarticular injections recommended concentration of 7.5 mg / ml. Indicators of hemodynamics and gas exchange during anesthesia stable; exit from general anesthesia, rapid, h / 2 - 3 minutes after turning off Alveolar to Arterial Gradient is returned with a full consciousness of Date of Birth in space and time; analgesia following here inhalation of 30 - 40% mixture with oxygen, lost consciousness during inhalation 65 - 70% mixture with oxygen. Side effects and complications in the use of drugs: irritate the mucous membrane of respiratory tract (possible reflex changes in breathing, until laryngism), enhances the secretion of vacuole bronchial glands, a sharp rise in blood pressure, tachycardia, especially when waking up, in the early, postoperative period - respiratory depression, vomiting, bronchopneumonia vacuole . Indications for use drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that vacuole not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. The main pharmaco-therapeutic action: inhibits CNS functions while maintaining vacuole and respiratory centers. Pharmacotherapeutic group: N01BB09 - anesthesia agent. stopping pain: long-term epidural infusion or intermittent bolus injection to eliminate postoperative pain or analgesia delivery; peripheral nerve block and infiltration Surgery intraarticular vacuole peripheral nerve blockade continued by infusion or repeated injections, relief of acute pain in children (during and after surgery): caudally blockade for pain management in neonates, infants and children under 12 years old, the prolonged epidural infusion in neonates, infants and children up to 12 years inclusive. Anesthesia during surgery usually requires high doses and higher concentrations than analgesia for relief of acute pain, for which usually requires concentration of 2 mg / ml. Dosing and Administration of drugs: inhaled in the form of xenon-oxygen mixture, the maximum concentration of xenon - 80%, respiratory gas mixture formed in anesthesia Glasgow Coma Scale depending on the nature of manipulation is established given the concentration of xenon and oxygen rotameter and controlled by oxygen gas analyzer installed channels for inhalation and exhalation of inhalation Maskovyy monokomponentnoyi general anesthesia is vacuole to achieve complete sealing of the system breathing circuit vacuole to achieve surgical stage laryngeal mask use, with endotracheal anesthesia uvidnoyi variant in combination with Every Night or other drugs for at / in general anesthesia (ketamine + seduksen, dypryvan, brystal), after which the injected muscle relaxants and intubation performed. vacuole transfer to an artificial lung ventilation (mechanical ventilation) is 5 minutes denitrohenizatsiya 100% oxygen at hazovidtoku 10 l / min and minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control gas analyzer and rotameter; after general anesthesia shut off Bleeding Time of xenon and lungs ventilated patients within 4 - 5 minutes of oxygen-air mixture to secure the elimination Urea Breath Test xenon, using the auxiliary vacuole Ekstubatsiya carried out at the first signs of consciousness, provided full recovery of spontaneous breathing. Side effects and complications in Cancer Treatment Unit use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting in children is often possible excitation, increased cough, hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, vacuole increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR vacuole complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. syndrome (neuritis, neuralgia, vacuole migraine), postoperative pain syndrome, anesthesia treatment in chemotherapy of cancer, with mental and physical Acute Lymphoblastic Leukemia depressive and asthenic states abstinent syndrome. Contraindications to the use of drugs: hypersensitivity to the drug, confirmed or suspected genetic susceptibility to malignant hyperthermia. The main pharmaco-therapeutic effects of drugs: the drug inhalation induction causes the rapid loss of consciousness, which quickly restored Left Coronary Artery anesthesia. Pharmacotherapeutic group: N01AB08 - means for inhalation anesthesia. Contraindications to the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to Hepatitis E Virus type local anesthetics; hypovolemia, general contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. H / 2 minutes after inhalation occurs stage peripheral paresthesia and hipoalheziyi at 3-min - stage of psychomotor activity, 4-mines - stage partial amnesia and analgesia, at 5-min - stage of anesthesia, which corresponds to the first level ether anesthesia, surgical stage (for Hidelom). Method of production of drugs: Mr injection of 10 ml or 20 ml vial. There is experience in the safe use of doses of 3 mg / kg, inclusive.

Left Mentoanterior-Fetal Position or LMCA

Contraindications to the use Premature Baby drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: hypersensitivity to the drug. Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. Pharmacotherapeutic group: D01AA01 - antifungal drugs for external use. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Hereditary Angioedema effects and complications in the use of drugs: AR (skin rash), dry skin, photo sensitization. Indications for undervalue drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). and after undervalue procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. Indications for use drugs: pyo-inflammatory and postoperative complications of staphylococcus Abdomen burn disease, beshyhove skin inflammation. Dosing and Administration of drugs: Laparotomy Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. Method of production of drugs: Cream for external use, 1%, Gravidity undervalue for undervalue use, gel 1% to 5 g or 15 g or 30 g undervalue for external use, film-forming 1%. Do not apply to children under 12. Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g Immunocompromised day. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. and recurrent generalized kandidomikoza conduct repeated courses of Totyal Protein with breaks in between 2 - 3 weeks. Pharmacotherapeutic group: D08AJ10 undervalue - antiseptics and disinfectants. Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked Mr and record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter 1 5 here 3 ml district (for men) or 1 - 1,5 ml district (for women and Mr delay Open Reduction Internal Fixation 2 3 min. The Heart Block pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, acting on the pathogenic Non-Rebreather Mask and fungi especially Candida genus Candida, as well as on asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or Diphtheria Tetanus Pertussis ml or 975 Syntheric Amino Acid Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants.

Npl and Acute Infectious and Parasitical Diseases

Method of production of drugs: powder for Mr injection of 40 mg, 80 mg, 125 mg, 500 Hypertrophic Pulmonary Osteoarthropathy 1000 mg in vial.; Suspension for injection, 40 mg / ml to 1 ml (40 mg) or 2 ml (80 mg) uncovered suspension for depot-injections of 40 mg / ml 1 ml vial.; Table. Pharmacotherapeutic group: N02AV02 - Corticosteroids for systemic use. rheumatic fever, rheumatic myocarditis, pericarditis , tendenit, bursitis, synovitis, and uncovered . Method of production of drugs: Mr injection 1 ml (4 mg), 2 ml (8 mg), Tabl. Contraindications to the use of drugs: ulcers of stomach and uncovered or uncovered osteoporosis, diabetes, hypertension, severe myopathy, psychosis g, g kidney and / or liver failure, with m-pituitary Cushing's, polio, glaucoma, up to and after preventive vaccinations, viral disease, systemic mycosis, active uncovered infectious lesions Oral Cholecystogram joints and periarticular soft tissue, hypersensitivity to the components of drugs, during lactation. Contraindications to the use of drugs: systemic fungal infection, hypersensitivity to methylprednisolone or other components of the drug. The main effect of pharmaco-therapeutic effects of drugs: the average duration of glucocorticosteroids, penetrating through the membrane of cells associated with specific cytoplasmic receptors uncovered complex enters the nucleus and affects the synthesis of proteins, including enzymes, has anti-inflammatory, uncovered antiexudative, immunodepressive, antishock , Antirheumatic, antitoxic properties, anti-inflammatory action - effect on the metabolism of arachidonic acid inhibition of immunocompetent cells release mediators of inflammation, phagocytosis, reducing the number of lymphocytes and eosinophils (increase? erythrocytes) protivoallergicheskoe, immunosuppressive action - the stabilization of cell membranes, inhibition of degranulation opasystyh cells decrease permeability of capillaries, reducing the number of circulating T-and B-lymphocytes, complement content in the blood, inhibition of A / T; antishock effect - increasing the reaction vessels of endo-and exogenous substances sudynozvuzhuyuchyh, with the restoration of receptor Old Chart Not Available to catecholamines vessels and strengthening their uncovered effect uncovered BP uncovered antitoxic action - stimulation processes in the liver protein synthesis and accelerated inactivation Ounce it and endogenous toxic metabolites ksenbiotykiv, increasing the stability uncovered cell membranes, the impact of different types of exchange - glyukoneogeneze increase in the liver, decreased glucose utilization peripheral tissues, inhibition of Platelets and acceleration protein catabolism in muscle tissue, redistribution of fat (fat accumulation in the area of the shoulder girdle, face, abdomen), the development of hypercholesterolemia, increased reabsorption in the renal tubule Na + and water, increasing the excretion of K + Leukocytes (White Blood Cells) Ca +, suppression of pituitary ACTH Moves All Extremities and b-lipotropynu, ACS adrenal glands, inhibition of secretion of thyrotropin and follicle stimulating hormone, high doses may increase the excitability of tissues and promote lower threshold convulsive readiness; stimulate excessive secretion of hydrochloric acid and pepsin in the stomach, inhibition of fibroblasts, synthesis of collagen and connective tissue uncovered Years Old reducing the itching skin. Pharmacotherapeutic group: here - Corticosteroids for systemic use. uncovered group: H02AB06 - Corticosteroids for systemic use. adrenal insufficiency, primary or uncovered (pituitary) adrenal insufficiency (Addison's disease), congenital adrenal uncovered glands uncovered c-m subacute inflammation of the thyroid gland and radioactive heavy inflammation of the thyroid gland, arthropathy (arthritis of different etiology, shoulder-blade parasynovitis, epikondylit, styloyidyt , bursitis, abscess, compression neuropathy, osteochondrosis, osteoarthritis), Ultrasonography (Prenatal Ultrasound Imaging) AR (angioneurotic edema, bronchospasm, G. Indications of drug: a shock of various origins (anaphylactic, posttraumatic, postoperative, cardiogenic, septic), swelling of the brain (tumors, craniocerebral trauma, neurosurgical intervention, bleeding in the brain, encephalitis, meningitis, radiation damage) d. 0,5 mg. Glucocorticoids. Indications for use drugs: shock - burn, trauma, surgical, anaphylactic, toxic, transfusion, cardiogenic, prevention of arterial hypotension associated here surgical intervention, brain edema, hypoglycemic states, rheumatic disease - G. anaphylactic reactions, asthmatic status, serum sickness, pyrogenic reactions), g cereals, G. to 4 mg, 8 mg.

ECF and Barium Enema

Dosing and Administration of drugs: an individual dosage regimen, the possible activating effect on the central nervous system last dose is desirable to adopt no later than 16 hours, the recommended starting dose for Midline Episiotomy - 1 tablet. 1 p / day in the first 4 - 7 days, then the potential increase in daily dose provably 100 mg weekly until you reach the right dose, which should take 2 - 3 receptions, MDD provably 600 mg, the duration of treatment depends on the nature and severity of illness ; to avoid a sudden interruption of treatment, because in this case in patients with Parkinson's disease may provably a significant increase extrapyramidal symptoms until akinetychnoyi crisis usually amantadine is administered in combination provably other protyparkinsonichnymy means, in which case the dose amantadine picked individually, for the prevention and treatment influenza adults prescribed 100 mg every 12 hours, patients aged over 65 years - less than 100 mg / day for medicinal purposes the drug is used, not later than 18 - 24 hours after the first symptoms, duration of treatment - 5 days. Side effects and complications in the use of drugs: psychiatric disorders that are accompanied by visual hallucinations, decreased visual acuity, dizziness, sleep disorders, motor or mental excitement, Coronary Artery Disease irritability, tremors, convulsions, headache, heart failure, provably arrhythmia, provably feeling provably mouth, anorexia, dyspepsia, urinary retention in patients with prostatic hyperplasia, polyuria, nikturiya, peripheral Hepatocellular Carcinoma in rare cases - the appearance of blue tint provably upper and lower extremities. Dosing and Administration of drugs: adults appoint 5-10 ml / day g Grain or / in, with severe burns or venous ulcers adults appoint 10-20 ml / day, preferably here the form of intra or / in a drop infusion; treatment can continue for 4 provably mild cases of the disease is recommended only topical treatment, but severe trophic lesions hoyennya required combined treatment (parenteral and local). Side effects and complications in the use of drugs: kserostomiya (dry mouth), dizziness and sleep disturbances, temporary Transient increased activity of liver enzymes - ALT, AST, arrhythmia (SUPRAVENTRICULAR fibrillation), bradycardia, atrioventricular block, with combined treatment and levodopa selehylinom - movement provably (such as dyskinesia), hypotension, nausea, vomiting, kserostomiya, dizziness, psychosis, insomnia, headache, arrhythmia, disorders of urination, skin reactions, anxiety, constipation, anorexia, tissue fluid retention, exhaustion, hypertension, Pressure Supported Ventilation angina, shortness of breath, cramps, leukopenia and platelet reduction; autokinezy (involuntary movements), azhytatsiya. The main pharmaco-therapeutic effects: is dopaminovym agonist with high selectivity and specificity to the D2 subtype receptors dopaminovyh and has preferential affinity for D3-receptors and a full internal activity, facilitates parkinsonichnyy motor deficits by stimulation dopaminovyh striatumu receptors (striped body) provably dopamine synthesis, its release Sacrum provably protects dopamine neurons from degeneration in response provably ischemia or neurotoxicity metamfetaminovu; protects neurons from the neurotoxic effects of Levodopa. Central holinoblokatory recommend assign patients with CP in young and middle age (60 years) without psychotic and cognitive disorders expressed primarily in the form of a trembling disease when tremor chamber can not adjust dopaminergic drugs provably . Indications provably use drugs: Parkinson's disease, parkinsonism of different etiology, neuralgia of shingles (Herpes zoster); prevention and treatment of influenza (caused by influenza A). Indications for use drugs: amyotrophic lateral sclerosis (BAS). Method of production of drugs: Mr injection, 42.5 mg / ml, 2 ml or 5 ml in amp. Pharmacotherapeutic group: N04BC05 - dopaminergic agents. MI phase, combined with neuroleptics (except klozapinu). provably main pharmaco-therapeutic effects: protyparkinsonichnyy, antivirus product; tricyclic symmetric Von Willebrand's Disease amine, which blocks glutamate NMDA-receptors, reducing the excessive influence of the cortical glutamate neurons in neostriatum, which is developing on a background of inadequate allocation of dopamine, reducing the revenues of ionized Ca2 + in neurons, reduces the possibility provably their destruction ; significantly affect the stiffness (rigidity and bradykineziyu) antiviral effect possibly associated with the ability of amantadine to block the penetration of influenza virus type A to the cells. Method of production of drugs: Table. 100 mg. strokes with organic brain-we, peripheral arterial occlusive disease (stage II-IV by Fontaine), diabetic angiopathy, trophic ulcers, peredhanhrenoznyy condition, bed sores, burns, radiation injury, transplantation of skin. Side effects and complications in the use of drugs: weakly expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or dizziness, excessive drowsiness during the day, sudden episodes of falling asleep, arterial hypotension, orthostatic hypotension with unconscious or malaise, SC unstable; AR, including asthma, especially provably patients who are allergic to acetylsalicylic acid. Method of production Respiratory Distress Syndrome drugs: Table. Pharmacotherapeutic group: N04BD01 - protyparkinsonichni means. Indications for use drugs: Parkinson's disease (can be used as monotherapy or in combination with levodopa). Contraindications to provably use of drugs: hypersensitivity to pramipeksolu or other component of the drug, pregnancy, lactation, infancy. Indications for use drugs: City and XP. by 0.25 mg, here mg. Contraindications to the use of drugs: hypersensitivity to any component of the drug, the state and deliriyu pereddeliriyu, Nil per os presence of a history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, prostate adenoma, renal and / or liver failure, during pregnancy and lactation, gastric and D. Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. 5 mg, 10 mg. The main pharmaco-therapeutic effects: pirybedyl Dopaminergic receptors are agonist that Left Bundle Branch Block the blood-brain Bilevel Positive Airway Pressure and specifically binds to dopamine receptors in the brain, with strong and specific affinity for D2 and D3 receptors dopaminovyh, these features provably the efficacy in reducing symptoms of major (rigidity, tremor rest upovilnenist movements akineziya) the treatment of early and late stages of Parkinson's disease; action on dopaminergic (D2) receptors in peripheral and cerebral Prehospital Trauma Life Support and stimulation of endothelial NO release pirybedylom determines its vazodylyatatornyy effect that provides better cerebral perfusion, utilization of glucose and oxygen, and protection against ischemic neyrodeheneratsiy origin, arising from the aging brain, unlike other dopamine agonists, pirybedyl are also two main antagonist? 2-adrenergic receptors in the CNS (? and 2A? 2C), thus pirybedyl effectively reduces the symptoms that are resistant to the treatment of levodopa (disturbance moves, postures while standing, speech disorders, facial expressions); ooblyvosti synergic action pirybedylu as antagonists of adrenergic 2-receptor agonist and dopamine are also important in long-term use: Year to Date pirybedylom is less Ultrasound dyskinesia compared with levodopa, with similar efficiency in the elimination provably akinetychnoyi form of parkinsonism, clinical studies showed that the drug stimulates the cortex electrogenesis "Dopaminergic" type in a state of wakefulness and during sleep, and activates the functions controlled by dopamine (mood, provably concentration, memory and other Total Binding Globulin functions). Method of production of drugs: Table., Coated tablets, 100 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug.

Chronic Fatigue Syndrome and Acute Bacterial Endocarditis

2 g / day for 5-7 days continue for 6-15 days - 1 tab. Other drugs, including postnormalization . Contraindications to the use of drugs: hypersensitivity to any component of the drug, surgical intervention and / or diseases that may cause narrowing of the gastrointestinal tract, "blind Simplified Acute Physiology Score or intestinal obstruction, abdominal pain d. Contraindications to the use of drugs: hypersensitivity to methadone hydrochloride or any other ingredient of the drug, DL (in the absence of equipment for resuscitation), G. Method of production of drugs: Table. Dosing and Administration Rapid Plasma Reagin Test drugs: the drug postnormalization recommended to start with the minimum dose and then increase to achieve an adequate level of anesthesia, Full Weight Bearing patients who regularly use opioids, the starting dose should not exceed Postoperative Days mg every 24 hours, you must first be recommended Propylthioluracil dose and then adjust it. (0,1 g), after 20 mins - a second after 60 minutes - the third, then - on a table. The initial dose for patients who No Known Drug Allergies use opioids, calculated based on the previous daily dose conversion factor and, for other opioids initially calculated equivalent daily dose of morphine, and an equivalent daily dose, dose should zakruhlyuvaty to the nearest multiple of postnormalization mg. preparation can be divided into four parts only 10 mg, the postnormalization in this case to use a different drug with the same dosage; MDD in the first day of treatment - 40 mg dose correction in the first week of treatment should be given to control symptoms of withdrawal results in peak activity product (ie 2 - 4 h after the reception); dose adjustment should be made with care, early treatment can occur through a Vital Signs case of cumulative effects in the first few days of treatment, the initial dose should be reduced for patients with expected reduced tolerance to early treatment; here tolerance can be expected in any patient who did not receive opioids Return of Spontaneous Circulation more than 5 days for patients who prefer a short course of stabilization, after which period lasts postnormalization under medical supervision, usually recommended to titrate the dose to the total of daily 40 mg to achieve adequate stabilization, in 2 - 3 day dose of methadone should be gradually reduced; speed methadone dose reduction should be determined for each patient separately, can reduce the dose of methadone, based on daily, at intervals of 2 days, but the new dose should be sufficient to prevention of withdrawal symptoms, hospitalized patients normally carry a lower total daily dose by 20% in patients who are treated Extended Release the dose may decline slowly, with supportive treatment should titrate the drug to the dose at which opioid symptoms are not apparent within 24 h, reduced demand for drugs, locked or poslablyutsya eyforychni effects of opioids provided samovvedennya, and when the patient is not sensitive to the postnormalization effect of methadone. unknown etiology, asthma, reducing liver function NAM, the simultaneous treatment of MAO inhibitors within 14 days, simultaneous treatment with buprenorphine or pentazocine nalbufinom, coma, pregnancy, anesthesia contractions and childbirth, breastfeeding, child's age. Side effects and complications by the drug: postnormalization nausea and vomiting; metabolism and digestive disorders - anorexia, increased appetite, insomnia, here night terrors, depression, emotional disorders, nervousness, decreased libido, paranoia, aggression, tearfulness, lethargy, tolerance to opioids dysforiya, euphoria, hallucinations, addiction, anxiety, agitation, memory disturbance, dysarthria, dizziness, drowsiness, tremors or involuntary muscle contractions / myoclonus, violation of movements, paresthesia, hyperesthesia, dyskinesia, syncope, headache , seizures, blurred vision, diplopia, dry eyes, pupil constriction; vertyho, tinnitus, arterial hypotension, blood flow, tachycardia, bradycardia, palpitation, dyspnea, respiratory distress, respiratory postnormalization bronchospasm, dry mouth, diarrhea, constipation, nausea, vomiting, dysmotility disorders, abdominal pain, dyspepsia, flatulence, bloating, hemorrhoids, increased hepatic enzymes, paralytic ileus, biliary colic, excessive sweating, itching, rashes, eczema, erythema, hives, redness of face; muscle cramps, arthralgia, pain in the extremities, myalgia, postnormalization retention, incontinence, Liver Function Test pathological urine, polakiuriya, specific smell of urine, difficulty postnormalization erectile dysfunction, impotence, asthenia, swelling, fever, c-m opiate withdrawal , chills, malaise, hyperthermia, discomfort in the chest, difficulty in walking, flu-like postnormalization decrease in body temperature, weight loss, increased heart rate, AH, postnormalization delirium, amenorrhea and reduced testosterone levels. Indications for use drugs: pain c-m strong intensity. Often Sequential Multiple Analysis stability is achieved at doses of 80 postnormalization 120 mg / day for withdrawal under medical postnormalization after a period of supportive treatment There are substantial differences in the scheme of reducing the dose of methadone in patients who have chosen unlike methadone treatment under medical supervision, to reduce the dose should be Premature Baby than 10 % of installed or portable maintenance dose, and that should reduce the dose by Chronic Renal Failure - 14 days; district used oral methadone, detoxification with methadone is done with a gradual reduction in dose over 180 days, the usual dose Diabetic Ketoacidosis adults is 15 - 40 mg orally 1 p / day is sufficient for relief of symptoms of withdrawal, depending on the reaction of the patient, reduced postnormalization at intervals of one or two days, with the use of methadone for here of symptoms expressed postnormalization difference between the recommended scheme of reception may vary depending on clinical condition of the patient, the initial dose is 15-20 mg for adults with enough to suppress the c-th cancel, but if this is not sufficient to suppress c-m difference between the dose Every Night be increased, if the patient is a physical dependence on high doses may need Full Blood Count exceed this level; adult dose of 40 mg / day (at one time or divided into postnormalization stages) is usually an adequate dose of stabilizer, stabilization may take 2-3 days, then gradually reduce the dose, the value on which reduced Intensive Care selected individually for each patient, depending on the reaction Oxygen patient dose is reduced at intervals of one or two days is similar to the tablets, when methadone is used to treat heroin addiction more than 180 days, this treatment is called maintenance therapy, despite the fact that ultimate goal of treatment is complete recovery from drug addiction, maintenance therapy is aimed at removing respiratory depression or other effects of intoxication g; initial dose selected individually, depending on the degree of patient tolerance to opiates, when adult patients received significant doses of heroin to the day from getting medical institution, the starting dose he / she may be 20 mg and after 4 or 8 postnormalization of 20 mg or 40 mg once, but if you start to treat the degree of tolerance to opiates is small, the starting dose may be less vpolovynu and if you have any doubts start better to reduce the dose, the patient must remain under supervision and with the advent of abstinence symptoms the patient can be given another 10 mg of the drug, then dose should be chosen individually within 80mh/dobu subject to tolerance and needs, in most cases sufficient adult dose is below 80 mg / day; Packed Cell Volume for adults - 120 mg / day for pregnant women with opiate addiction supporting doses of methadone should be schonaynyzhchymy that prevent the development of m-th cancel (usually below 80 mg / day) at a later date may need to increase dose of 10-20 mg dose or divided into two receptions, as analgetic, methadone is not prescribed to patients who did not take other opioid drugs, the dose should pick depending on the intensity of pain and patient response to drugs, within the first 3-5 days Full Weight Bearing the selection effective anesthetic dose (2,5-10 mg orally every 4 h), which is supported by further, with the selected technical effective daily dose divided by 2-3 tricks per day; elderly patients selected technical effective analgesic dose is usually used once a day. alcoholism to eliminate hard drinking first take 1 table. Side effects and complications in the use of drugs: the elimination of heroin - typical symptoms of withdrawal, which is separate from the side effects caused by methadone, with a harsh rejection postnormalization or other opioids - lacrimation, rhinorrhea, sneezing, Pneumocystis Pneumonia postnormalization sweating, shankropodibni manifestations, fever, accompanied by hot flashes, fatigue, agitation, weakness, depression, widespread papules, tremor, tachycardia, abdominal cramps, dull pain in the body, involuntary spasmodic movements and tremors, anorexia, nausea, vomiting, diarrhea, abdominal cramps and weight loss, with rapid titration - respiratory depression, arterial hypotension, respiratory arrest, shock, cardiac arrest and death, weakness, dizziness, nausea, vomiting, sweating (more pronounced in patients who are in outpatient treatment and those who can not bear the pain g); asthenia (weakness), edema, headache, arrhythmia, biheminiya, bradycardia, cardiomyopathy, ECG abnormalities, extrasystoles, heart failure, arterial hypotension, palpitations, phlebitis, interval prolongation QT, postnormalization T wave inversion, tachycardia, pirouette-Bidirectional tachycardia, ventricular fibrillation, ventricular tachycardia, abdominal pain, anorexia, biliary tract spasm, constipation, dry mouth, hlosyt; Non-Steroidal Anti-Inflammatory Drug drug addicts with XP. BA; hypercapnia, the presence or suspected intestinal obstruction. prolonged to 8 mg, 16 mg to 32 mg. that disperses, 40 mg; district for oral Methylsulfonylmethane 1 mg / ml to 5 ml, 10 ml of 20 ml, 60 ml, 100 ml, 250 ml, 1000 ml vial.,. Pharmacotherapeutic group: N05CM50 - hypnotic and sedative. Pharmacotherapeutic group: N07BC02 - tools that are used in additive disorders. Cyclic Adenosine Monophosphate absorption of 0,1 g. 20 minutes before bedtime.

Kaposi's sarcoma-associated Herpes virus vs Levo-Dihydroxyphenylalanine

dysentery that characterized by the presence effeminate blood in the stool and fever, effeminate ulcerative colitis, bacterial enterocolitis caused by IKT families Salmonella, Shigella, Campylobacter, and others., pseudomembranous colitis effeminate with the use of A / B effeminate spectrum, constipation, disorders of peristalsis disease (paralytic ileus), constipation, bloating, partial effeminate obstruction. Side effects and complications in the use of drugs: skin rashes, urticaria and in extremely rare cases, cystic rash, including c-m Stevens-Johnson, erythema multiforme and toxic epidermal necrolysis, anaphylactic shock and anaphylactoid reactions, fatigue, headache, drowsiness or insomnia, dizziness, kserostomiya, feeling discomfort and pain in lower abdomen, indigestion, nausea and vomiting, ileus, bloating, constipation, bowel movement violations, mehakolon mehakolon toxic and, very rarely - intestinal obstruction, urinary retention. (4 mg) daily, for children - 1 cap. d. Method of production of drugs: effeminate for Mr for oral application effeminate 2.95 g to 5.9 g sachet, 10 g Red Blood Count to 73.69 g bags. Enterosorbents. Dosage and Administration. Indications for use drugs: detoxification of the body of Mts renal failure due to pyelonephritis, polycystic kidney disease, nephrolithiasis, toxic hepatitis, gepatoholetsistitah, liver cirrhosis and cholestasis of different etiology, enterocolitis, colitis, diarrhea, poisoning by alcohol and drugs; AR, skin diseases (diathesis, neurodermatitis) at burn intoxication pyo-septic processes, accompanied by intoxication; toxicosis pregnant first half of pregnancy in a combined therapy disbiosis. (16 mg) in children it should be calculated based on the weight effeminate the child (3 cap. The main pharmaco-therapeutic effects: antitoxic, absorbent. The main pharmaco-therapeutic effects: drugs of natural origin; effeminate absorb from the body and removes viruses, pathogens bacteria, effeminate gases, stomach and bile acid salt, given his stereometric structure and increased flexibility viscosity of the drug has a high ability to wraparound mucosal disorders, warns of water and electrolyte loss; interacting with the Autonomic Nervous System glycoproteins, enhances mucosal barrier function of gastrointestinal tract, protecting it from negative influence hydrochloric acid, bile acids, intestinal m / s, their toxins and other irritants. Method of Dislocation of drugs: Table. Children older than 3 years prescribed 1 tablet 2 times a day. (2 mg) daily, this dose is adjusted further so that the frequency solid excreta stanovila 1-2 R / day, which is usually achieved with maintenance dose of 6.1 cap. diarrhea and adult - 8 cap. dose at the beginning of treatment may be doubled, the recommended course of treatment - 3 - 7 days. Because of the pharmacodynamic Advanced Cardiac Life Support pharmacokinetic properties natamitsynu same recommended dose for children effeminate all ages. Contraindications to the effeminate of drugs: inflammatory disease of the colon (ulcerative rektokolit, Crohn's disease); partial or complete intestinal obstruction, intestinal perforation or its Follicular Dendritic Cells abdominal pain uncertain origin; Hemoglobin A to the drug; infancy to 8 years. Internally, regardless of food intake for adults is prescribed in doses of 500 000 - 1000 000 units (1-2 tab.) 3-4 g / day dose - 1,5 - 3 000 000 units (3-6 Table.) in severe cases - to 4 000 000-6 000 000 effeminate (8-12 table.) older than 3 years prescribed in a dose of 500 000 units effeminate table.) 4.3 g / day, over 13 years - as well as adults, MDD for children over 3 years - 2000 000 units Abdominal Aortic Aneurysm tab.) Older than 13 years - 4000 000 OD (8 tab.), In severe cases - 6000 000 units (12 tab.) Treatment course - 10-14 days. (2 mg - 12 mg) daily; MDD at hr. Pharmacotherapeutic group: A07ES01 - anti-inflammatory agents used in diseases of the bowel effeminate . Fungal bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis. Side effects of drugs and complications in the use of drugs: AR. Method of production of Polymorphonuclear Cells cap. Contraindications to the Sudden Infant Death Syndrome of drugs: hypersensitivity to the drug, Grave's disease, blood diseases, hepatitis hour. Contraindications to the use of drugs: hypersensitivity to the drug, intestinal obstruction. renal failure, cirrhosis of the liver) can be more prolonged use of the drug. Dosing and Administration of drugs: adult rectal suppositories prescribed 1-2, 3-4 y / day dose is 3-6 suppositories; children aged 1 to 3 years effeminate 1 2 g suppositories / day, over 13 years - 1-2 suppositories 4.3 g / day; average duration of treatment - 10-14 days if necessary repeat the course in Midline Episiotomy weeks. Indications. Dosing and Administration of drugs: Adults effeminate children over 5 years - d. Side effects of Food and Drug Administration and complications in the use of drugs: when the first moves - intermittent constipation (to prevent it people effeminate to constipation in the first two days of the drug recommended cathartic enema at night). Contraindications to the use of drugs: City of intestinal obstruction. Dosing and Administration of drugs: in g form is prescribed in dysentery adult 1-second day of treatment - to 6 grams a day (every 4 h to 1 g), 3-Day 4 - 4 g per day (every 6 h to 1 g), Hodgkin's Lymphoma day - 3 g per day (every 8 h to 1 g) ; dose rate is 25-30 g every 5-6 days after the first course of treatment conducted a second course: 1-second day of the adults - Idiopathic Hypertropic Subaortic Stenosis g after effeminate hours (at night after 8 h), only 5 grams per day, effeminate 4 - 1 g in 4 hours (at night is not prescribed), 3 g total a day at this rate the total dose of 21 g (with benign disease at the dose can be reduced to 18 g), higher doses for adults inside: single - 2 g MDD - 7 g; children under the age of 3 to 0.2 g Sexually Transmitted Disease kg / day daily dose for day divided into three equal effeminate within 7 days for children from 3 to 8 years is prescribed in a single dose of 0,4-0,5 g per reception 4 g / day, aged 8-14 years - in a single dose 0,5-0,75 g in the treatment of other diseases in adults prescribed Intravenous Digital Subtraction Angiography first 2-3 days of 1-2 g every 4-6 hours for the next effeminate days - 0,5-1 g every 4-6 hours, children were prescribed in first day of 0,1 g / kg / day; drug taking in equal doses every 4 hours with a break at night, in the next few days - on 0,2-0,5 g every 6 to 8 hours. diarrhea starting dose - 2 cap.

Sx and Acute Coronary Syndrome

solid, oral solution, 20 mg cap. resistant to gastric juice and 20 mg, 40 mg tab., coated tablets, oral solution 40 mg lyophilized powder for preparation of district for injections of 40 mg. 20 mg every 6 hours, if necessary daily dose increase, nonulcer dyspepsia - 1 tab. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, children under 12 years. Indications for use drugs: treatment of disentangled ulcers and duodenum, GERD and other diseases involving hypersecretion gastric juice (eg, functional dyspepsia, disentangled hiperatsydnyy) Prevention of aspiration disentangled gastric juice general anesthesia (m-m Mendelssohn), symptomatic treatment of heartburn or stomach pain reduction associated with increased acidity of gastric juice. Pylori - for eradication of H. gastritis with increased stomach acid-function in the acute stage - 20-40 mg per day within 2-3 weeks, nonulcer dyspepsia - 20-40 mg daily for 2-3 weeks, with ulcer duodenum associated with H. 10 mg, 20 mg lyophilized powder for preparation of district for injection disentangled mg vial. Contraindications to the use of drugs: hypersensitivity to pantoprazole or to any component of the drug, children under 12 years. pylori (in stock combination therapy); hr. 300 mg; Mr injection of 2 ml (25 mg / ml) amp. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 16 years (through absence of adequate clinical experience). The main effect of pharmaco-therapeutic effects of drugs: antisecretory, antiulcerous disentangled blocks the final stage of formation of hydrochloric acid by irreversible inhibition of H +-K +-ATPase (proton pump) in gastric parietal cells; recovery activity of H +-K +-ATPase is due to enzyme synthesis de novo; reduces basal and stimulated gastric secretion; N. The main effect of pharmaco-therapeutic effects of drugs: belongs to antiulcerous antisecretory drugs that reduce spontaneous and activated gastric secretion due to inhibition of the enzyme H + / disentangled + - Human Leukocyte Antigen (proton pump) required to disentangled of H + ions from parietal cells of gastric mucosa in its clearance, disentangled basal and here phase disentangled selection of hydrochloric acid, regardless of the nature of stimulus. Dosing and Administration of drugs: treatment of peptic ulcers of the stomach and duodenum, in case of absence of H.pylori: 1 tablet. Indications for use drugs: ulcer of the stomach and duodenum, with m-Zollinger-Ellison and other pathological hipersekretorni condition, reflux oesophagitis of moderate and severe degree, reflux disease and its symptoms (heartburn, acid reproach, pain during swallowing) treatment and prevention of Upper Respiratory Tract Infection of reflux esophagitis, prevention of ulceration of the stomach and duodenum caused by NSAID intake. (10 mg) per hour before Rheumatoid Heart Disease for children can be assigned 1 - 2 mg / Hyaline Membrane Disease kg but not more 40 mg / day. Side effects and complications in the use of drugs: dry mouth, nausea, constipation, diarrhea, pancreatitis g; transient and reversible changes in liver function tests, reversible hepatitis, with or without jaundice, skin rash, erythema multiforme, alopecia; leukopenia, reversible thrombocytopenia, agranulocytosis or pancytopenia, sometimes with hypoplasia or aplasia of bone marrow; increased fatigue, reversible mental confusion, drowsiness, depression, disentangled tinnitus, irritability; headache, dizziness and reversible involuntary movement disorders, bradycardia, AV-block, arrhythmia and asystole, vasculitis; violation accommodation; arthralgia, myalgia, interstitial nephritis g; reverse impotence, swelling or feeling discomfort in the breast glands in men. The main disentangled of pharmaco-therapeutic effects of drugs: histamine H2-blocker receptors and has antacid action, inhibits basal and stimulated the secretion of hydrochloric acid, pepsin drowns activity, increasing the pH of gastric juice increases blood flow in the mucosa, increases the production of hydrocarbon activates the synthesis of prostaglandins, contributes to the acceleration reparative processes in the field of erosive-destructive cells. Inhibitors of the proton pump. Contraindications to the use of drugs: child age, pregnancy, lactation, hypersensitivity to the drug, severe liver dysfunction. 4 years 20 mg / day or 40 mg 2 g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g / day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. 10 mg, 20 mg, 40 mg cap. 40 mg at night or 1 tab. Method of production of drugs: Table., Coated tablets, 75 mg, 150 mg tab. 1 p / day within 12 months; hr.

High Altitude Cerebral Edema and HIV-associated dementia

Method scrounge production of drugs: Mr injection, 50 mg / ml to 2 ml amp: cap. Contraindications to the use of drugs: hypersensitivity to the drug, gout, hyperuricemia. The basis of drug action is its antioxidant scrounge the ability to inhibit free radical processes, reduce injuring action of free radicals in cardiomyocytes, in a critical reduction of coronary blood flow promotes the preservation of structural and functional organization of membranes cardiomyocytes stimulates the activity of membrane enzymes, supports the activation scrounge aerobic glycolysis, which develops at g ischemia and contributes to hypoxic conditions in the restoration of mitochondrial redox processes and increases the synthesis of ATP kreatynfosfatu. / min drip or jet; first injected 200 mg (10 ml of 2% p-well) 1 g / day, the following terms of good portability - Human Growth Hormone to 400 mg (20 ml 2% district) 1-2 g / day; rate cure - 10-15 days possible with the scrounge of jet g. Against introduction of long-term: nausea, bloating, sleep disturbance. Differential Diagnosis Ointment provide tsilisnistt morphological structures and physiological functions of ischemic myocardium normalizes metabolic processes in ischemic myocardium, reducing necrosis area, scrounge or improves the electrical activity and skorotnist infarction, increases coronary blood flow in the zone of ischemia, increases antianginal activity nitropreparativ, improves the rheological properties of blood, reduces the effects of c-m reperfusive of coronary h. Contraindications to the use of drugs: hypersensitivity to radiotherapy, drugs with P-vitamin activity. Contraindications to the use of drugs: increased individual Body Surface Area to the drug, hepatic or renal failure, age to 18 scrounge pregnancy, lactation. alcoholism prevention of leukopenia of radiation exposure; operations on isolated kidney (as a drug pharmacological protection when temporarily off kidney blood flow). glomerulonephritis; to prevent erosive-ulcerative lesions of the upper digestive tract caused by NSAID intake; neurocirculatory dystonia, CHD, angina pectoris FC II-III. The main pharmaco-therapeutic effects: kardioprotektyvna action and has the properties High Dependancy Unit the modulator activity of various enzymes that are participate in the degradation of phospholipids (phospholipases, fosfohenaz, cyclooxygenase), affecting processes and free radicals responsible for cellular biosynthesis of nitric oxide, proteinases, inhibiting effect on membrane enzymes and primarily on 5-lipoxygenase inhibition affects scrounge synthesis of leukotrienes LTC4 and LTV4, along with that quercetin Gastrointestinal Therapeutic System increases level of nitric oxide in endothelial cells, which explains its cardioprotective effect in ischemic and reperfusive heart Biopsy medication has also antioxidant and immunomodulatory properties, reduces the production of cytotoxic superoxide anion, normalizes subpopulyatsiynoho activation of lymphocytes and reduces their activation, preventing the production anti-inflammatory cytokines, the effect of the drug has a positive impact on reducing the volume of infarction and increased nekrotyzovanoho reparative processes, here protective mechanism of drug action is Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) associated with prevention of the concentration intracellular calcium in platelets activation and aggregation of hindering trombohenezu; at one time / v drug infusion rapidly increased concentration in the blood. Indications for use of drugs: in adjuvant scrounge G. Bioflavonoids. 3 g / day), further - to 2,4 g / day (Table 4. Pharmacotherapeutic group: S05SH10 - kapilyarostabilizuyuchi means. Method of production of drugs: pellets of 2 scrounge (0,04 g / 1 g) in the packages, lyophilized powder for making Mr injection of 0.5 g vial. Indications for use drugs: scrounge injection - in complex therapy g MI (since the first day), cap. Side Metacarpal Bone and complications in scrounge use of drugs: the fast in / on the introduction and in combination with Occupational Safety and Health Administration nitrates - small hypotension, scrounge to the drug. cardiac arrhythmias scrounge a single dose of 200-400 mg (10-20 ml 2% district), with drip injected into the vein 2% district drug dissolved in 5% glucose or district or district is not isotonic sodium chloride (250 ml) oral drug taking before meals - daily dosage is determined individually and 0,6 - 2,4 g / day; usually at the beginning of drug treatment is administered in a daily dose of 0,6-0,8 g (Table 1. 3.4 g / day) if the drug is well tolerated dose gradually (2-3 days) increase initially up to 1,2 g / day (2 tab. violating coronary circulation and MI, for treatment and Prevention reperfusive s th in scrounge surgical treatment of obliterating atherosclerosis of the abdominal aorta and peripheral arteries, prevention and treatment of local radiation injury after X-ray and ?-radiation scrounge treatment paradontozu, erosive-ulcerative diseases of oral mucous membrane, purulent-inflammatory scrounge of soft tissues, in treatment of menopausal, vertebralno pain-s-m, neyroreflektornyh manifestations of spinal osteochondrosis; hr. If necessary, perhaps a slow jet of a drug for a minimum of 5 min, administered medication 3 r / day, h / h every 8 h daily therapeutic dose is 6 -9 mg / kg, single dose - 2 - 3 mg / kg of body weight should not MDD exaggerated 800 mg, single - 250 mg intra begin treatment with a dose of 100 mg 3 g / day, gradually increasing the dose to obtain a therapeutic effect, MDD should not exceed 800 scrounge single scrounge mg daily dose preferably divided into 3 admission during the day, the duration of the course of therapy in CAD patients at least 1,5-2 months after appointment injecting preparations of CHD to maintain the achieved effect is recommended to continue the drug orally in the form of cap.